Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure

by Gregor Poglajen, Gregor Zemljič, Andraž Cerar, Sabina Frljak, Martina Jaklič, Vesna Androcec, Bojan Vrtovec
Published 2019-07-01

Stem Cell Therapy in Patients with Chronic Nonischemic Heart Failure

by Gregor Poglajen, Gregor Zemljič, Sabina Frljak, Andraž Cerar, Vesna Andročec, Matjaž Sever, Peter Černelč
Published 2018-01-01

Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart Failure

by Gregor Poglajen, Jus Ksela, Sabina Frljak, Gregor Zemljic, Elizabeta Boznar Alic, Andraz Cerar, Bojan Vrtovec
Published 2019-01-01

Transendocardial CD34 Cell Transplantation in Noncompaction Cardiomyopathy

by Andraz Cerar, Gregor Zemljic, Sabina Frljak, Martina Jaklic, Gregor Poglajen, Matjaz Sever, Marko Cukjati, Bojan Vrtovec
Published 2018-07-01

Long-Term Effects of Angiotensin Receptor–Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection Fraction

by Gregor Poglajen, Ajda Anžič-Drofenik, Gregor Zemljič, Sabina Frljak, Andraž Cerar, Renata Okrajšek, Miran Šebeštjen, Bojan Vrtovec
Published 2020-07-01

Response to the letter to the editor: unravel the genetic background of noncompaction before relating it with myocardial hypoperfusion

by Andraz Cerar, Martina Jaklic, Sabina Frljak, Gregor Poglajen, Gregor Zemljic, Barbara Guzic Salobir, Maja Dolenc Novak, Monika Stalc, Rok Zbacnik, Mirta Kozelj
Published 2020-08-01

Impairment of myocardial perfusion correlates with heart failure severity in patients with non‐compaction cardiomyopathy

by Andraz Cerar, Martina Jaklic, Sabina Frljak, Gregor Poglajen, Gregor Zemljic, Barbara Guzic Salobir, Maja Dolenc Novak, Monika Stalc, Rok Zbacnik, Mirta Kozelj
Published 2020-06-01